Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma

Journal of Thoracic and Cardiovascular Surgery

Volumn 142, Issue 2, 2011, Pages 384-389

  Watzka, Stefan B ^a   Posch, Florian ^a,b   Pass, Harvey I ^c   Huflejt, Margaret ^c   Bernhard, David ^b   Hannigan, Gregory E ^d   Müller, Michael R ^a  

^a OTTO WAGNER HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE DEHYDROGENASE; ASBESTOS; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; INTEGRIN LINKED KINASE; LACTATE DEHYDROGENASE;

AGED; ARTICLE; BLOOD SAMPLING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; CYTOLYSIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; EXPOSURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT PLEURAL MESOTHELIOMA; PLEURA MESOTHELIOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; THORAX DISEASE;

AGED; BIOLOGICAL MARKERS; CELL TRANSFORMATION, NEOPLASTIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; SENSITIVITY AND SPECIFICITY;

EID: 79960398747     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.04.034     Document Type: Article

References (25)

1. A.A. Mujoomdar, T.R. Tilleman, W.G. Richards, R. Bueno, and D.J. Sugarbaker Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens J Thorac Cardiovasc Surg 140 2 2010 352 355
2. A. Scherpereel, P. Astoul, P. Baas, T. Berghmans, H. Clayson, and P. de Vuyst Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma Eur Respir J 35 2010 479 495
3. T.D. Yan, M. Boyer, M.M. Tin, D. Wong, C. Kennedy, and J. McLean Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors J Thorac Cardiovasc Surg 138 2009 619 624
4. N.J. Vogelzang Chemotherapy for malignant pleural mesothelioma Lancet 371 2008 1640 1642 (Pubitemid 351671872)
5. M.F. McAleer, A.S. Tsao, and Z. Liao Radiotherapy in malignant pleural mesothelioma Int J Radiat Oncol Biol Phys 75 2009 326 337
6. H. Yang, J.R. Testa, and M. Carbone Mesothelioma epidemiology, carcinogenesis, and pathogenesis Curr Treat Options Oncol 9 2008 147 157
7. G.E. Hannigan, C. Leung-Hagesteijn, L. Fitz-Gibbon, M.G. Coppolino, G. Radeva, and J. Filmus Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase Nature 379 1996 91 96 (Pubitemid 26008142)
8. C. Tan, A. Mui, and S. Dedhar Integrin-linked kinase regulates inducible nitric oxide synthase and cyclooxygenase-2 expression in an NF-kappa B-dependent manner J Biol Chem 277 2002 3109 3116 (Pubitemid 34953171)
9. G. Hannigan, A.A. Troussard, and S. Dedhar Integrin-linked kinase: a cancer therapeutic target unique among its ILK Nat Rev Cancer 5 2005 51 63 (Pubitemid 40052325)
10. N. Yoganathan, A. Yee, Z. Zhang, D. Leung, J. Yan, and L. Fazli Integrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties Pharmacol Ther 93 2002 233 242 (Pubitemid 34615564)
11. S.B. Watzka, U. Setinek, M. Huber, H. Cantonati, F. Lax, and S. Watson Reactivity of integrin-linked kinase in human mesothelial cell proliferation Interact Cardiovasc Thorac Surg 7 2008 107 110 (Pubitemid 351239942)
12. S.B. Watzka, U. Setinek, E.B. Stubenberger, M. Tötsch, G. Dekan, and M. Marcher Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma Eur J Cardiothorac Surg 39 2011 180 184
13. Z. An, K. Dobra, J.G. Lock, S. Strömblad, A. Hjerpe, and H. Zhang Kindlin-2 is expressed in malignant mesothelioma and is required for tumor cell adhesion and migration Int J Cancer 127 2010 1999 2008
14. N. Ahmed, K. Oliva, G.E. Rice, and M.A. Quinn Cell-free 59 kDa immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma Clin Cancer Res 10 2004 2415 2420 (Pubitemid 38445701)
15. D. Cox, M. Brennan, and N. Moran Integrins as therapeutic targets: lessons and opportunities Nat Rev Drug Discov 9 2010 804 820
16. C. Théry, L. Zitvogel, and S. Amigorena Exosomes: composition, biogenesis and function Nat Rev Immunol 2 2002 569 579 (Pubitemid 37328732)
17. J.P. Hegmans, M.P. Bard, A. Hemmes, T.M. Luider, M.J. Kleijmeer, and J.B. Prins Proteomic analysis of exosomes secreted by human mesothelioma cells Am J Pathol 164 2004 1807 1815 (Pubitemid 38529783)
18. S.B. Watzka, I. Rauscher-Pötsch, E. Stubenberger, V. Getman, U. Setinek, and M. Tötsch Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection Eur J Cardiothorac Surg 38 2010 254 259
19. B.W. Robinson, J. Creaney, R. Lake, A. Nowak, A.W. Musk, and N. de Klerk Mesothelin-family proteins and diagnosis of mesothelioma Lancet 362 2003 1612 1616 (Pubitemid 37443528)
20. A. Scherpereel, B. Grigoriu, M. Conti, T. Gey, M. Grégoire, and M.C. Copin Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma Am J Respir Crit Care Med 173 2006 1155 1160 (Pubitemid 43726897)
21. J. Creaney, D. Yeoman, Y. Demelker, A. Segal, A.W. Musk, and S.J. Skates Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma J Thorac Oncol 3 2008 851 857
22. E.K. Park, A. Sandrini, D.H. Yates, J. Creaney, B.W. Robinson, and P.S. Thomas Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study Am J Respir Crit Care Med 178 2008 832 837
23. H.I. Pass, D. Lott, F. Lonardo, M. Harbut, Z. Liu, and N. Tang Asbestos exposure, pleural mesothelioma, and serum osteopontin levels N Engl J Med 353 2005 1564 1573 (Pubitemid 41434635)
24. B.D. Grigoriu, A. Scherpereel, P. Devos, B. Chahine, M. Letourneux, and P. Lebailly Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment Clin Cancer Res 13 2007 2928 2935 (Pubitemid 46850705)
25. K. Iwahori, T. Osaki, S. Serada, M. Fujimoto, H. Suzuki, and Y. Kishi Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin Lung Cancer 62 2008 45 54